World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. - Wikidata - awgldk - TriplyDB

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.

http://www.wikidata.org/entity/Q34744755

about

Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?Bifeprunox versus placebo for schizophrenia MicroRNA dysregulation in psychiatric disease Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression Clinical practice guidelines in psychiatry: more confusion than clarity? A critical review and recommendation of a unified guideline Following the genes: a framework for animal modeling of psychiatric disorders Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks.Neuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research.Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample.Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis.Pharmacogenetics of antipsychotics.The appropriateness of routine medication treatment for schizophrenia.Potential molecular and cellular mechanism of psychotropic drugs Efficacy and tolerability of aripiprazole: a 26-week switching study from oral antipsychotics.Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Drug safety and efficacy evaluation of sertindole for schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Pharmacotherapy for treatment-resistant schizophrenia.Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.Safety and tolerability of antipsychotics: focus on amisulpride.Pharmacogenetics of antipsychotic-induced side effects Comparative effectiveness research for antipsychotic medications: how much is enough?Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection.Quo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Context.Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study.Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison Use of clozapine for the treatment of schizophrenia: findings of the 2006 research on the china psychotropic prescription studies Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia.Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study Psychosocial Rehabilitation Training in the Treatment of Schizophrenia Outpatients: A Randomized, Psychosocial Rehabilitation training-and Monomedication-Controlled Study Principles of antipsychotic prescribing for policy makers, circa 2008. Translating knowledge to promote individualized treatment.A review of the safety and tolerability of aripiprazole.

P2860

Q22242820-E7154110-5289-4790-AFC7-303A48D1C2C0 Q24186774-316E5074-70CD-4F65-AB74-252A7779AB7C Q24630375-3B867176-068B-4A90-AF07-2A33E217BFD4 Q26747833-29B7D1C8-9DE3-4AD6-8DD1-A7AD100FDBFC Q26830411-B38EC256-56C8-4C13-99D8-8D0DAE388924 Q26830603-21B91995-AC79-4E84-BE06-3F0A5A67C917 Q28727394-E95D0DD1-C4B3-45CA-AFB3-0929B72644AC Q30370326-37FE475C-5E10-49B7-BD9C-3623417A22C9 Q30582343-15063C8F-E9D1-4F81-A662-75431A6285B4 Q33545458-D1047FDC-48B3-4079-A9CD-704639CD7AE0 Q33627482-88AD1110-C7FF-432C-8257-188E1F3170BF Q33818732-8DC9A1F6-D9F9-4686-9F20-5A5F42C4CD42 Q33836837-24C2E439-9F91-4AFF-9CB4-99049D42D5EF Q33950877-703BB804-2433-4EEA-9187-91B5C3A8E496 Q34129880-64C55530-19F9-463B-BFFB-18523E56541A Q34165051-79379D56-C239-4657-B5AB-B14CE7FB3DE6 Q34254903-24E35E05-8BC9-4778-A02D-60CF5E87061B Q34274859-1CB71D7E-4DC7-4605-96E8-BD3D1CA87FB9 Q34300628-FF61D233-A80E-48B4-BE4C-722015CD1D3B Q34640811-8287791C-FEE2-4DB3-8FBA-77B3FEFB5AC5 Q34879109-6DFCB3C4-9E9D-4939-A9EE-857FB637DD99 Q34960871-6672A40E-661D-4202-A4B3-2B49F329991E Q35002529-CF2AD202-0168-443C-8B7B-5E64C12DD8CD Q35026487-2E138CFD-5E13-4C99-B073-77E7858AF79E Q35237129-77C5676A-1080-4E39-98A9-1A2F7B6DF91F Q35622982-3FD18977-0371-43E3-8AF6-1820C9FC2EAE Q35709035-0A6F8318-591B-414F-8D71-41093547EFBE Q35776860-6B493A0C-7A7A-458D-9A5D-B6838BD1FC3A Q35795401-C939ABBF-6F1B-472E-93F2-E4C26775BC23 Q35974641-28B62772-5EF5-4354-846F-AEDBD625A12B Q36168439-9D061E88-7A95-406F-8711-C7D5E4DE0684 Q36184331-17AB20B7-902F-4A61-8971-0F545D468EBA Q36223890-C13FFEA2-3146-4BC0-93CE-7A17072617B0 Q36325431-4D4C0AD9-DD0C-4B7E-BFB9-645E10A56B80 Q36600791-3F6616C4-9D21-4003-90EA-24E76DF1EEB9 Q36990173-8333BF73-04B2-4C0D-80EC-C4362DCADFB3 Q37220015-0221720D-17C2-452D-A003-DF6A3F8C54EE Q37257986-8098C960-BC63-4539-A930-B80C65F26C39 Q37310164-3E4271D4-21AC-4414-B586-DD0F4A1A8506 Q37510958-1A65C053-E3A8-4F35-88D6-FF292A7A0338

P2860

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.

http://www.wikidata.org/entity/Q34744755

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

World Psychiatric Association ...... he treatment of schizophrenia.

@ast

World Psychiatric Association ...... he treatment of schizophrenia.

@en

World Psychiatric Association ...... he treatment of schizophrenia.

@nl

type

label

World Psychiatric Association ...... he treatment of schizophrenia.

@ast

World Psychiatric Association ...... he treatment of schizophrenia.

@en

World Psychiatric Association ...... he treatment of schizophrenia.

@nl

prefLabel

World Psychiatric Association ...... he treatment of schizophrenia.

@ast

World Psychiatric Association ...... he treatment of schizophrenia.

@en

World Psychiatric Association ...... he treatment of schizophrenia.

@nl

P1433

Q34744755-41D527D7-1A40-4DF9-8F39-CC0918282605

P1476

Q34744755-B6BC1C82-7306-4802-85D9-AF58971B98E4

P2093

Q34744755-10D60301-D57E-44D6-9841-B0C783D4DE82

Q34744755-1359CCA5-F641-4501-AB42-33917EE5CFB7

Q34744755-3E4EDEA8-A16F-437F-AFFE-CB2283CD914B

Q34744755-427DD652-CD9B-4D37-9181-0727700BA0BE

Q34744755-44163547-410E-4DAE-9D25-85C21D427C49

Q34744755-7BFAA2F9-0D17-418C-971E-C6CF131D2866

Q34744755-96B37B45-04DF-4F94-AD10-7304E6A27DA2

Q34744755-97EE825C-D533-4B9C-8948-703803D6434F

Q34744755-B43C65A7-D48D-418A-A1E1-63DC0B7E498D

Q34744755-D37924FF-E388-4BBE-A036-80A0938BB12F

P304

Q34744755-1F512575-B046-452A-A009-C6A35F0AC2CD

P31

Q34744755-535B4F71-087D-4A5F-AEB8-BC03EC5E47A3

P356

Q34744755-D445DAD4-A7D7-4D18-813D-5739EE398047

P407

Q34744755-A792C04B-C8A9-4DA6-8647-F44572B8DEFD

P433

Q34744755-9B03621E-5F21-40F3-8D42-11C7DF3E77A0

P478

Q34744755-BB3544B9-F2C4-4E93-B917-EDABD84C7B8C

P50

Q34744755-6E55223E-13C1-4F50-916C-4EFCF1B78E38

P577

Q34744755-CB2DD640-BBAF-4888-B55D-72917FB4D4D5

P5875

Q34744755-7CA1F1DB-BB58-4342-9765-49A81A855795

P698

Q34744755-CEBE6E8E-7CCD-437B-9D79-AA49D1784AEC

P921

Q34744755-CC317B11-3FD6-4C30-A8A2-1827ED8EB69C

P356

J.SCHRES.2007.11.033

P1433

Schizophrenia Research

P1476

World Psychiatric Association ...... he treatment of schizophrenia.

@en

P2093

Ahmed Okasha

http://www.w3.org/2001/XMLSchema#string

Bruce Singh

http://www.w3.org/2001/XMLSchema#string

Hans-Juergen Moeller

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Olie

http://www.w3.org/2001/XMLSchema#string

Juan J Lopez-Ibor

http://www.w3.org/2001/XMLSchema#string

R H Belmaker

http://www.w3.org/2001/XMLSchema#string

Rajiv Tandon

http://www.w3.org/2001/XMLSchema#string

Section of Pharmacopsychiatry, World Psychiatric Association

http://www.w3.org/2001/XMLSchema#string

W Wolfang Fleischhacker

http://www.w3.org/2001/XMLSchema#string

Wagner F Gattaz

http://www.w3.org/2001/XMLSchema#string

P304

20-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SCHRES.2007.11.033

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5607848

http://www.w3.org/2001/XMLSchema#string

P698

18243663

http://www.w3.org/2001/XMLSchema#string

P921